TLRY Stock Analysis: Buy, Sell, or Hold?
TLRY - Tilray Brands, Inc. Common Stock
$7.46
-0.16 (-2.10%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Jan 12, 2026
0d
Get Alerted When TLRY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
8 traders called TLRY this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: TLRY is down 17.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: TLRY is down 17.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: TLRY is currently trading at $7.46, which is considered oversold relative to its 30-day fair value range of $8.43 to $9.88. From a valuation perspective, the stock is trading at a discount (Forward PE: -26.6) compared to its historical average (201.6). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, TLRY is in a strong uptrend. The price is currently testing key support at $7.52. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $11.82 (+55.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TLRY is in a strong uptrend. The price is currently testing key support at $7.52. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $11.82 (+55.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$8.43 -
$9.88
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
84.3%
Protect Your Profits
Holding TLRY? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 55.2% below Wall St target ($11.82)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Recommendation downgraded due to -17.6% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$8.43 -
$9.88
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$7.52
Resistance Level
$9.68
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-26.62
Wall Street Target
$11.83
(+55.2%)
Revenue Growth (YoY)
3.1%
Profit Margin
-251.7%
PE vs Historical
-26.6 vs 201.6
CHEAP
Last updated: January 31, 2026 12:38 AM ET
Data refreshes hourly during market hours. Next update: 1:38 AM
Data refreshes hourly during market hours. Next update: 1:38 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TLRY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$179 | 62 BUY |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$158 | 56 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$84 | 57 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 55 HOLD |
|
HCM
HUTCHMED DRC |
STRONG BUY
14 analysts |
$21 | 57 HOLD |
Advanced TLRY Option Strategies
Professional options setups generated by AI based on today's TLRY price and gamma walls.
